Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New acetamide derivatives developed at SS Pharm. for diabetic complications

May 5, 1999

Amylin's AC-2993 yields encouraging results in type II diabetes study

May 5, 1999

Takeda initiates clinical testing with osteogenesis-promoting agent

May 4, 1999

Azolidinedione derivatives for improving insulin resistance

May 4, 1999

Unimed submits NDA for Androgel

May 4, 1999

BioMarin completes financing, gears up to file first BLA

May 4, 1999

Alizyme selects potential antiobesity product emerging from collaboration

May 3, 1999

SCRC-2941-18: new IL-6 inhibitor with potential for osteoporosis

May 3, 1999

New beta3-agonist characterized in vitro by SB

May 3, 1999

Bone Care International: Q3 1999 highlights

May 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...